Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease
characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and …

Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease with a chronic,
progressive course. Various aspects of PsA, including its clinical features, disease course …

The aims of this systematic review and meta-analysis were to:(1) describe the prevalence of
commonly reported comorbidities in psoriatic arthritis (PsA),(2) compare the incidence …

Psoriatic disease (PsD) is a heterogeneous condition that can affect peripheral and axial
joints (arthritis), entheses, skin (psoriasis) and other structures. Over the past decade …

Objective Sex differences may modify symptoms, disease expression, and treatment effects.
The objective of this study was to evaluate the link between life impact and sex in psoriatic …

Background Comorbidities are frequent in psoriatic arthritis (PsA) and may contribute to
worse health-related outcomes. Patient-reported outcomes (PROs) are used to evaluate the …

Background Evaluate the impact of sex on tofacitinib efficacy, safety and persistence (time to
discontinuation) in patients with psoriatic arthritis (PsA). Methods Data were pooled from two …

Background Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an
important factor in individualized patient treatment planning and healthcare policy and …

Background Sex-related differences in clinical manifestations and disease outcomes exist in
psoriatic arthritis, however, there is limited information on sex-related differences in …

Objective There is a lack of real‐life studies on interleukin‐17 (IL‐17) inhibition in psoriatic
arthritis (PsA). We assessed real‐life 6‐and 12‐month effectiveness (ie, retention, remission …